Diagnostic Hematopathology: Review and Update of Selected Topics

Date: March 9-12, 2010
Location: Palm Springs, CA
Credits: 27.25 CME

Core Competencies: PC, MK, ICS, PBL, PR, SBP
Intended Audience: Pathologists, Pathology Residents, Medical Technologist

Stay on the cutting edge with new information about:

• Essentials of the revised WHO Classification system for leukemias, lymphomas, and myeloproliferative/ myelodysplastic disorders
• Incorporation of molecular diagnostics into the practice of hematopathology

Special course features:

• Case reviews via video microscopy
• Learner engagement using audience response equipment
• Course syllabus included
• SAM credits (on-line pre and post-test required)

Let the distinguished faculty guide you in what you need to know about advances in the field, including the value of molecular diagnostic techniques and other new tests, special tests that provide vital information, and flow cytometry and immmunohistochemical stains. Get coaching by the faculty using cases projected via video microscope. Bring your challenging slides for discussions with the faculty and evaluate your knowledge with self-assessment options. If you’re interested in updating your knowledge about and enhancing your proficiency in classic morphologic hematology investigation in tandem with the many special new diagnostic tests –including flow cytometry, cytogenetics, immunohistochemical stains, and molecular diagnostics, this course is a “must” for you. In four days, you’ll move from a review of the essential conditions involving the blood and bone marrow to a thorough update on the latest developments. And you’ll gain new levels of diagnostic confidence in writing pathology reports.

Following this course, you will be able to:

• Define and apply an approach to the diagnosis of anemias.
• Appropriately apply criteria for the diagnosis of the acute leukemias, myeloproliferative disorders, chronic lymphoproliferative disorders, non-Hodgkin’s lymphoma and Hodgkin’s lymphoma.
• Utilize flow cytometry and molecular diagnostics in the evaluation of lymphomas and leukemias.
• Recommend appropriate molecular diagnostic testing in the evaluation of thrombophilia.

The ASCP designates these educational activities for a maximum of 27.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activities.

This activity meets MOC Part II Lifelong Learning requirements. A self-assessment option is available for pathologists attending this program to earn SAM credits for Maintenance of Certification, Part II Self-Assessment Modules (MOC-SAM) for part of the course.